Skip Navigation LinksHome > January 2007 - Volume 26 - Issue 1 > Evaluation and Treatment of Children With Ocular Rosacea
doi: 10.1097/ICO.0b013e31802e3a54
Clinical Science

Evaluation and Treatment of Children With Ocular Rosacea

Donaldson, Kendall E MD, MS; Karp, Carol L MD; Dunbar, Mark T OD

Collapse Box


Purpose: To describe the clinical presentation and treatment of ocular rosacea in children, an often unrecognized entity.

Methods: Retrospective chart review of 20 patients (age, 22 months to 17 years) who presented during childhood with corneal pathology, lid margin disease, and skin changes consistent with ocular rosacea. All patients were evaluated by the Cornea/External Disease Division of a tertiary-care facility, Bascom Palmer Eye Institute, Miami, FL, between 1990 and 2003.

Results: Sixty percent of patients improved after treatment with systemic erythromycin or doxycycline and topical low-dose steroid preparations. Ten percent of patients experienced no change in symptoms with treatment, and 30% of patients had incomplete follow-up to determine success of treatment. The patients maintained remission for up to 4 years after a slow taper of systemic treatment. The mean length of follow-up was 19.6 months (range, 0-9 years).

Conclusions: Early recognition and treatment of ocular rosacea in children may improve patient outcome by limiting progression of corneal pathology, including scarring and vascularization.

Copyright © 2007 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.